TY - JOUR
T1 - Telestroke Across the Continuum of Care
T2 - Lessons from the COVID-19 Pandemic
AU - Guzik, Amy K.
AU - Martin-Schild, Sheryl
AU - Tadi, Prasanna
AU - Chapman, Sherita N.
AU - Al Kasab, Sami
AU - Martini, Sharyl R.
AU - Meyer, Brett C.
AU - Demaerschalk, Bart M.
AU - Wozniak, Marcella A.
AU - Southerland, Andrew M.
N1 - Funding Information:
The authors would like to acknowledge the support of Anne Leonard and other members of the American Heart Association/ American Stroke Association (AHA/ASA) Telestroke Committee. Grant Support: None
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/7
Y1 - 2021/7
N2 - While use of telemedicine to guide emergent treatment of ischemic stroke is well established, the COVID-19 pandemic motivated the rapid expansion of care via telemedicine to provide consistent care while reducing patient and provider exposure and preserving personal protective equipment. Temporary changes in re-imbursement, inclusion of home office and patient home environments, and increased access to telehealth technologies by patients, health care staff and health care facilities were key to provide an environment for creative and consistent high-quality stroke care. The continuum of care via telestroke has broadened to include prehospital, inter-facility and intra-facility hospital-based services, stroke telerehabilitation, and ambulatory telestroke. However, disparities in technology access remain a challenge. Preservation of reimbursement and the reduction of regulatory burden that was initiated during the public health emergency will be necessary to maintain expanded patient access to the full complement of telestroke services. Here we outline many of these initiatives and discuss potential opportunities for optimal use of technology in stroke care through and beyond the pandemic.
AB - While use of telemedicine to guide emergent treatment of ischemic stroke is well established, the COVID-19 pandemic motivated the rapid expansion of care via telemedicine to provide consistent care while reducing patient and provider exposure and preserving personal protective equipment. Temporary changes in re-imbursement, inclusion of home office and patient home environments, and increased access to telehealth technologies by patients, health care staff and health care facilities were key to provide an environment for creative and consistent high-quality stroke care. The continuum of care via telestroke has broadened to include prehospital, inter-facility and intra-facility hospital-based services, stroke telerehabilitation, and ambulatory telestroke. However, disparities in technology access remain a challenge. Preservation of reimbursement and the reduction of regulatory burden that was initiated during the public health emergency will be necessary to maintain expanded patient access to the full complement of telestroke services. Here we outline many of these initiatives and discuss potential opportunities for optimal use of technology in stroke care through and beyond the pandemic.
KW - COVID-19 (4), Pandemic (5)
KW - Coronavirus (7)
KW - SARS CoV-2 (6)
KW - Stroke (8)
KW - Stroke care (9)
KW - Stroke delivery (10)
KW - Telemedicine (2)
KW - Teleneurology (3)
KW - Telestroke (1)
UR - http://www.scopus.com/inward/record.url?scp=85104106280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104106280&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2021.105802
DO - 10.1016/j.jstrokecerebrovasdis.2021.105802
M3 - Article
C2 - 33866272
AN - SCOPUS:85104106280
SN - 1052-3057
VL - 30
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 7
M1 - 105802
ER -